Ignition of calcium sparks in arterial and cardiac muscle through caveolae

Circ Res. 2000 Nov 24;87(11):1034-9. doi: 10.1161/01.res.87.11.1034.

Abstract

Ca(2+) sparks are localized intracellular Ca(2+) events released through ryanodine receptors (RyRs) that control excitation-contraction coupling in heart and smooth muscle. Ca(2+) spark triggering depends on precise delivery of Ca(2+) ions through dihydropyridine (DHP)-sensitive Ca(2+) channels to RyRs of the sarcoplasmic reticulum (SR), a process requiring a very precise alignment of surface and SR membranes containing Ca(2+) influx channels and RyRs. Because caveolae contain DHP-sensitive Ca(2+) channels and may colocalize with SR, we tested the hypothesis that caveolae are the structural element necessary for the generation of Ca(2+) sparks. Using methyl-ss-cyclodextrin (dextrin) to deplete caveolae, we found that dextrin dose-dependently decreased the frequency, amplitude, and spatial size of Ca(2+) sparks in arterial smooth muscle cells and neonatal cardiomyocytes. However, temporal characteristics of Ca(2+) sparks were not significantly affected. We ruled out the possibility that the decreases in Ca(2+) spark frequency and size are caused by changes in DHP-sensitive L-type channels, SR Ca(2+) load, or changes in membrane potential. Our results suggest a novel signaling model that explains the formation of Ca(2+) sparks in a caveolae microdomain. The transient elevation in [Ca(2+)](i) at the inner mouth of a single caveolemmal Ca(2+) channel induces simultaneous activation and thus opens several RyRs to generate a local Ca(2+) release event, a Ca(2+) spark. Alterations in the molecular assembly and ultrastructure of caveolae may lead to pathophysiological changes in Ca(2+) signaling. Thus, caveolae may be intimately involved in cardiovascular cell dysfunction and disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aging / metabolism
  • Animals
  • Animals, Newborn
  • Caffeine / pharmacology
  • Calcium / metabolism
  • Calcium Channels, L-Type / drug effects
  • Calcium Channels, L-Type / metabolism
  • Calcium Signaling / drug effects
  • Calcium Signaling / physiology*
  • Caveolae / metabolism*
  • Caveolae / ultrastructure
  • Cell Membrane / metabolism
  • Cell Membrane / ultrastructure
  • Cell Separation
  • Cells, Cultured
  • Cholesterol / metabolism
  • Cyclodextrins / pharmacology
  • Dose-Response Relationship, Drug
  • Muscle, Smooth, Vascular / cytology
  • Muscle, Smooth, Vascular / metabolism*
  • Myocardium / cytology
  • Myocardium / metabolism*
  • Patch-Clamp Techniques
  • Phosphodiesterase Inhibitors / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Ryanodine / pharmacology
  • Sarcoplasmic Reticulum / metabolism
  • beta-Cyclodextrins*

Substances

  • Calcium Channels, L-Type
  • Cyclodextrins
  • Phosphodiesterase Inhibitors
  • beta-Cyclodextrins
  • methyl-beta-cyclodextrin
  • Ryanodine
  • Caffeine
  • Cholesterol
  • Calcium